Consun Pharmaceutical Group Limited
HKEX:1681.HK
8.61 (HKD) • At close November 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Consun Pharmaceutical Group Limited |
Symbool | 1681.HK |
Munteenheid | HKD |
Prijs | 8.61 |
Beurswaarde | 7,145,645,640 |
Dividendpercentage | 6.8% |
52-weken bereik | 4.38 - 8.88 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Qian Li |
Website | https://www.chinaconsun.com |
An error occurred while fetching data.
Over Consun Pharmaceutical Group Limited
Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)